Angiogenin: a review of the pathophysiology and potential clinical applications (Q33999348)

30 July 2017

1 reference

title

Angiogenin: a review of the pathophysiology and potential clinical applications (English)

1 reference

30 July 2017

1 reference

Tello-Montoliu A

1

1 reference

30 July 2017

Patel JV

series ordinal

2

1 reference

30 July 2017

Lip GY

series ordinal

3

1 reference

30 July 2017

publication date

1 September 2006

1 reference

Journal of Thrombosis and Haemostasis

30 July 2017

published in

1 reference

30 July 2017

volume

4

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

1864-1874

1 reference

Amino acid sequence of human tumor derived angiogenin

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Cloning and sequencing of the intronless gene for angiogenin, a human angiogenesis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Structure-function relationships in human ribonucleases: main distinctive features of the major RNase types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Characteristic ribonucleolytic activity of human angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenins: a new class of microbicidal proteins involved in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

3'-N-Alkylamino-3'-deoxy-ara-uridines: a new class of potential inhibitors of ribonuclease A and angiogenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Role of glutamine-117 in the ribonucleolytic activity of human angiogenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Amino acid sequence of the nonsecretory ribonuclease of human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Isolation and sequencing of mouse angiogenin DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Dual site model for the organogenic activity of angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Organogenesis and angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

A putative angiogenin receptor in angiogenin-responsive human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Isolation of angiogenin from normal human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenin activates endothelial cell phospholipase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Neomycin inhibits angiogenin-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Actin is a binding protein for angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Alpha-actinin-2, a cytoskeletal protein, binds to angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

The cytoskeleton and related proteins in the human failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Primary structure of human placental ribonuclease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Enhanced protein profiling arrays with ELISA-based amplification for high-throughput molecular changes of tumor patients' plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Physiology of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenin mRNA in human tumor and normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Divergence towards a dead end? Cleavage of the divergent domains of ribosomal RNA in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Extracellular matrix-dependent regulation of angiogenin expression in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenin distribution in human term placenta, and expression by cultured trophoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

An angiogenin-binding protein from endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenic factors are elevated in overweight and obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

A Study of the Intracellular Routing of Cytotoxic Ribonucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Humanization of immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Angiogenin antagonists prevent tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Genetic and environmental determinants of circulating levels of angiogenin in community-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01995.X

10.1111/J.1538-7836.2006.01995.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference